PATENT CLAIM ANALYSIS

Application Number: 15747545
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "093200"]

Abstract:
There is provided adenoviral vectors encoding a mycobacterial antigen derived from a chimp adenovirus, and to related aspects.

Claim (Index 107):
The adenovirus according to  claim 96 , wherein the polynucleotide comprises at least one of the following:\n (a) an adenoviral 5\u2032-end, preferably an adenoviral 5\u2032 inverted terminal repeat; (b) an adenoviral E1A region, or a fragment thereof selected from among the E1A_280R and E1A_243R regions; (c) an adenoviral E1B or IX region, or a fragment thereof selected from among the group consisting of the E1B_19K, E1B_55K or IX regions; (d) an adenoviral E2b region; or a fragment thereof selected from among the group consisting of the E2B_pTP, E2B_Polymerase and E2B_IVa2 regions; (e) an adenoviral L1 region, or a fragment thereof, said fragment encoding an adenoviral protein selected from the group consisting of the L1_13.6k protein, L1_52k and L1_IIIa protein; (f) an adenoviral L2 region, or a fragment thereof, said fragment encoding an adenoviral protein selected from the group consisting of the L2_penton protein, L2_pVII, L2_V, and L2_pX protein; (g) an adenoviral L3 region, or a fragment thereof, said fragment encoding an adenoviral protein selected from the group consisting of the L3_pVI protein, L3_hexon protein and L3_protease; (h) an adenoviral E2A region; (i) an adenoviral L4 region, or a fragment thereof said fragment encoding an adenoviral protein selected from the group consisting of the L4_100k protein, the L4_33k protein and protein L4_VIII; (j) an adenoviral E3 region, or a fragment thereof selected from a group consisting of E3 ORF1, E3 ORF2, E3 ORF3, E3 ORF4, E3 ORF5, E3 ORF6, E3 ORF7, E3 ORF8, and E3 ORF9; (k) an adenoviral L5 region, or a fragment thereof said fragment encoding the L5_fiber fiber protein; (1) an adenoviral E4 region, or a fragment thereof selected from a group consisting of E4 ORF7, E4 ORF6, E4 ORF4, E4 ORF3, E4 ORF2, and E4 ORF1; (m) an adenoviral 3\u2032-end, preferably an adenoviral 3\u2032 inverted terminal repeat; and/or (n) an adenoviral VAI or VAII RNA region.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.05263
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13147193', '14632433', '15623723', '15380123', '16098303']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7532350747634521
- 35 USC 102 Novelty (BERT): 0.5154640792843687
- Combined Prediction Score: 0.7294579752155438
- Mean Citation Score: 299.396434
- Max Citation Score: 322.2323
- Similarity Product: 265.0208520958662

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test